Access
Improving affordable and equal access to innovative therapies in hematology for patients across Europe is EHA’s overriding advocacy priority. EHA has published four position papers on key aspects of the highly complex, interwoven set of challenges around access:
Position papers
- EHA position paper on affordable access to OMPs
- EHA position paper on Fair pricing of innovative medicines
- EHA position paper on Precision Diagnostics
- EHA position paper on Personalized Medicine
Back